Nabla Bio
by Nabla Bio · enterprise · Last verified 2026-03-25
Nabla Bio develops AI-powered tools for drug discovery and development. Their platform leverages machine learning to analyze biological data, identify potential drug candidates, and optimize clinical trials, accelerating the drug development process.
https://www.nabla.bio/ ↗B+
B+—Good
Adoption: B+Quality: AFreshness: A+Citations: BEngagement: B+
Specifications
- License
- Proprietary
- Pricing
- enterprise
- Capabilities
- target-identification, drug-design, clinical-trial-optimization, biomarker-discovery
- Integrations
- AWS, Google Cloud, Benchling
- Use Cases
- pharmaceutical-research, personalized-medicine, drug-repurposing, rare-disease-research
- API Available
- Yes
- Tags
- drug-discovery, biotech, machine-learning, genomics, clinical-trials
- Added
- 2026-03-25
- Completeness
- 100%
Index Score
73.8Adoption
75
Quality
85
Freshness
90
Citations
65
Engagement
70
Put AI to work for your business
Deploy this startup alongside autonomous AaaS agents that handle tasks end-to-end — no babysitting required.